Trial of AZD5363 Plus Paclitaxel /AZD2014 Plus Paclitaxel in Biomarker Negative (PIK3CA/MEK/RAS/TP53/MET) Gastric Adenocarcinoma Patients as Second-line Chemotherapy

Clinical trial NCT02449655 · TERMINATED

Trial details

NCT number: NCT02449655
Sponsor: Samsung Medical Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Adenocarcinoma

Start date: 2015-02-12
Primary completion: 2018-07-16
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.